Dr. Nir Barzilai's perspective is that Big Pharma pours significant money into drug development but none into development for aging as a disease indication because the FDA has not yet approved aging as a disease indication, despite aging being the number one risk factor for most chronic diseases.
causalpending
Speaker
Ford BrewerEvidence Quote
“dr. Barzilai is very excited about the idea of approving a medication for the indication of aging his point is the Big Pharma pour a lot of money into drug development but none of them are pouring money into drug development for aging because fda has yet approved aging as a disease indication”
Created: 8/11/2026, 1:17:18 AM
Your notes
Loading notes...